Results 271 to 273 of about 31,601 (273)

Long‐term efficacy and safety of biosimilar infliximab (CT‐P13) after switching from originator infliximab: open‐label extension of the NOR‐SWITCH trial

Journal of Internal Medicine, 2019
exaly  

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

BioDrugs, 2013
exaly  

Biosimilar

Ya Wang, Qinqin Xu, Xiangyu Zhang
openaire   +1 more source